New Zealand markets closed

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
29.36+0.54 (+1.87%)
At close: 04:00PM EDT
31.00 +1.64 (+5.59%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 431.58M
Enterprise value 347.48M
Trailing P/E 0.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.50
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.13

Trading information

Stock price history

Beta (5Y monthly) 2.18
52-week change 362.21%
S&P500 52-week change 327.86%
52-week high 331.00
52-week low 34.00
50-day moving average 319.98
200-day moving average 312.28

Share statistics

Avg vol (3-month) 3131.29k
Avg vol (10-day) 3124k
Shares outstanding 515.06M
Implied shares outstanding 615.06M
Float 810.22M
% held by insiders 16.15%
% held by institutions 155.97%
Shares short (15 Mar 2024) 4327.3k
Short ratio (15 Mar 2024) 42.27
Short % of float (15 Mar 2024) 42.38%
Short % of shares outstanding (15 Mar 2024) 42.17%
Shares short (prior month 15 Feb 2024) 4282.04k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 304 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-60.09%
Return on equity (ttm)-112.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -67.75M
Net income avi to common (ttm)-64.47M
Diluted EPS (ttm)-61.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)86.89M
Total cash per share (mrq)5.77
Total debt (mrq)2.79M
Total debt/equity (mrq)3.55%
Current ratio (mrq)7.19
Book value per share (mrq)7.03

Cash flow statement

Operating cash flow (ttm)-52.07M
Levered free cash flow (ttm)-30.35M